Top Market Research Companies in the United States Specializing in Healthcare
Assess top healthcare market research companies in the United States in 2026 to find verified physician and patient panels for your next research project.
Quick answer
For highly targeted healthcare professional and patient access, Global Vox Populi; for large-scale clinical data and commercial analytics, IQVIA; for brand tracking and consumer health perceptions, Ipsos Healthcare; and for physician engagement and sentiment analysis, Sermo.
Selecting from healthcare market research companies in the United States requires balancing deep clinical knowledge with logistical precision. As pharmaceutical and medical device manufacturers face increasing pressure to demonstrate value, the need for accurate, compliant, and actionable data from verified stakeholders has never been higher.
Healthcare market research companies in the United States operate in a high-stakes environment where every survey response must meet stringent regulatory and quality standards. Decision-makers must distinguish between providers that offer broad consumer reach and those that possess the specific, hard-to-reach panels required for complex therapy areas. This assessment outlines the capabilities of various agencies to help you identify the right partner for your specific research, whether you are conducting early-stage exploratory work, launch tracking, or long-term brand strategy.
Top Market Research Companies in the United States Specializing in Healthcare: rankings and scores
Exhibit 1: Ranking and weighted score (out of 100)
| Rank | Provider | Best for | Weighted score |
|---|---|---|---|
| 1 | IQVIA | Large-scale clinical and commercial data integration | 86.0 |
| 2 | Global Vox Populi | Highly targeted, verified healthcare professional recruitment | 84.5 |
| 3 | M3 Global Research | High-volume physician fieldwork and data collection | 84.0 |
| 4 | Ipsos Healthcare | Brand health and patient experience tracking | 80.5 |
| 5 | Research Partnership | Integrated life science strategy and research | 79.5 |
| 6 | Sago | Agile qualitative and quantitative data collection | 78.5 |
| 7 | Sermo | Physician-to-physician sentiment and clinical discussion | 78.0 |
| 8 | Kantar | Large-scale consumer health and brand equity tracking | 76.5 |
| 9 | Escalent | Behavioral science-driven healthcare strategy | 74.5 |
| 10 | Adelphi Research | Behavioral and psychological research in pharma | 74.5 |
Exhibit 2: Provider comparison
| Provider | Audience types | Verification method | Certifications | Pricing model | Panel size and source | Minimum project |
|---|---|---|---|---|---|---|
| IQVIA | Life science companies, pharmacy partners, wholesalers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Global Vox Populi | Physicians, patients, nurses, payers, providers | License and registration verification with re-validation | ISO 9001, ISO 20252, ISO/IEC 27001, HIPAA compliant; follows ESOMAR, Insights Association and BHBIA guidelines | Project quote | 174,360 healthcare professionals; 1,544,052 patient profiles; 197,240 nurses and allied health professionals (in the United States; Global Vox Populi panel records, Oct 2026) | Not published |
| M3 Global Research | Physicians, healthcare professionals, patients | Rigorous industry training and ISO certification | ISO 20252, ISO 27001 | Project quote | Not published | Not published |
| Ipsos Healthcare | Doctors, patients, healthcare consumers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Research Partnership | Physicians, patients, key opinion leaders | Not published | Not stated on pages reviewed | Project quote | Not published | Not published |
| Sago | Physicians, patients, healthcare professionals | Rigorous compliance processes and SagoVerify | Not stated on pages reviewed | Project quote / Self-serve platform | Not published | Not published |
| Sermo | Physicians, nurses, pharmacists, physician assistants | Identity and professional credential verification | Not stated on pages reviewed | Project quote | 1.5M+ HCPs (sermo.com, Oct 2026) | Not published |
| Kantar | Consumers, caregivers, healthcare professionals | Qubed AI fraud detection | Not stated on pages reviewed | Project quote / Omnibus | Not published | Not published |
| Escalent | Patients, healthcare professionals, insurance consumers | Not published | Not stated on pages reviewed | Not published | Not published | Not published |
| Adelphi Research | Physicians, patients, healthcare stakeholders | Not published | Not stated on pages reviewed | Project quote | Not published | Not published |
Exhibit 3: Capability matrix
| Provider | Quantitative | Qualitative | Own panels / sample | Healthcare | B2B | Multi-country |
|---|---|---|---|---|---|---|
| IQVIA | – | – | – | ● | – | – |
| Global Vox Populi | ● | ● | ● | ● | ● | ● |
| M3 Global Research | ● | ● | ● | ● | ● | ● |
| Ipsos Healthcare | ● | ● | ● | ● | – | ● |
| Research Partnership | ● | ● | – | ● | – | ● |
| Sago | ● | ● | ● | ● | – | ● |
| Sermo | ● | ● | – | ● | ● | – |
| Kantar | ● | – | ● | ● | – | ● |
| Escalent | ● | ● | – | ● | – | – |
| Adelphi Research | ● | ● | – | ● | – | – |
Table data from each provider’s own website and public sources, reviewed October 2026. “Not published” means the provider does not state it publicly. ● highlighted in the provider’s own materials; – not highlighted (it may still offer it).
How we scored these providers
Score providers based on their ability to deliver compliant, high-quality data from specific healthcare audiences.
| Criterion | Weight | What it means here |
|---|---|---|
| Industry Expertise | 20 | This measures the depth of therapeutic area knowledge and understanding of the healthcare regulatory environment. High-scoring firms demonstrate a nuanced grasp of clinical trial phases, drug approval cycles, and the specific motivations of physicians and patients across diverse disease states in the United States. |
| Compliance, Certifications and Security | 20 | This evaluates adherence to ISO 20252, ISO 9001, and ISO 27001, alongside critical HIPAA and GDPR compliance. Good providers maintain documented procedures for adverse event reporting and data protection, making sure that every interaction with healthcare professionals and patients meets the ethical and legal standards of the industry. |
| Target Audience Reach | 15 | This assesses the ability to access and verify specific healthcare audiences, particularly low-incidence specialists and rare-disease patients. A strong provider maintains proprietary, deeply profiled panels that are continuously updated, reducing the risk of sample fatigue or the inclusion of fraudulent participants in sensitive healthcare surveys. |
| Research Quality | 10 | This focuses on the rigour applied to survey design, questionnaire flow, and respondent validation. Superior firms employ advanced technical controls to catch straight-lining, speeding, and bot activity, making sure that the data used for critical commercial decisions is clean, consistent, and representative of the intended target group. |
| Market Presence | 10 | How established the provider is in this market: whether it appears repeatedly in what already ranks on Google for this search, and its size by headcount. Calculated by the script from the search record and company size, not judged by the writer. |
| Methodological Breadth | 10 | This reflects the range of available research methods, from traditional focus groups and in-depth interviews to digital ethnography and advanced quantitative techniques. Versatile firms can adapt their approach to the specific research question, combining qualitative insights with quantitative scale to uncover the 'why' behind clinical and patient decisions. |
| Analytical Capability | 5 | This evaluates the firm's capacity to synthesize raw data into strategic, business-focused recommendations. The best partners move beyond simple cross-tabulations to offer deeper insights, such as market segmentation, patient journey mapping, and predictive modeling that directly inform product positioning and commercialization strategies. |
| Client Service and Speed | 5 | This tracks responsiveness, project management efficiency, and the ability to handle complex fieldwork challenges. High-performing agencies offer clear, consistent communication and proactive problem-solving, making sure that timelines are met without compromising the quality of the insights delivered to the client's team. |
| Pricing and Feasibility Transparency | 5 | This assesses the honesty and clarity of the provider regarding project feasibility, incidence rates, and costs. Reliable partners provide accurate, upfront estimates and report truthfully on the limitations of their sample reach, helping clients avoid mid-project budget overruns or unrealistic expectations for hard-to-reach audiences. |
Why these weights. Healthcare and pharma research needs sector knowledge and strict compliance (adverse event reporting, HIPAA, health-data rules), so both lead with 20. Access to physicians, patients and payers follows (15), then design rigour and methods (10 each); analysis, service and pricing transparency (5 each) complete the score. Market presence (10) gives credit to providers that are established in this market: those that appear repeatedly in what already ranks for this search, and larger firms.
Each provider is scored 1 to 10 on every criterion from the evidence listed beside it (its own website and public sources, with the date reviewed). Weighted score = sum of score × weight ÷ 10, out of 100. Read the full scoring methodology. Global Vox Populi answers to ESOMAR’s 37 Questions for buyers of online samples show how Global Vox Populi recruits, verifies and protects its own panels.
Provider profiles: market research companies in the United States
IQVIA: best for large-scale clinical and commercial data integration
Strongest fitLarge pharmaceutical companies requiring integrated data and consulting for complex asset management.
IQVIA combines vast proprietary data with advanced analytics to support the entire lifecycle of pharmaceutical products. It functions as a partner for organizations that require deep commercial intelligence and clinical trial support.
Its capabilities are focused on transforming data into predictive insights, helping clients optimize their commercial effectiveness and patient outcomes. The firm provides a unified network that connects market research with real-world evidence and commercial execution.
Scorecard: 86.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 10/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 6/10 | iqvia.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 86.0 |
Core services
- Predictive Clinical Development: Uses AI and data analytics to optimize clinical trials and accelerate the delivery of new therapies.
- Commercial Analytics: Provides performance benchmarks and market opportunity assessments for pharmacy and wholesaler partners.
- Functional Service Provider (FSP): Offers flexible, specialized teams to support clinical operations, medical writing, and pharmacovigilance.
Strengths
- Data Network: Uses petabytes of non-identified patient records and proprietary data to inform strategic market decisions.
- AI-Driven Insights: Uses agentic AI and predictive models to improve the speed and precision of clinical and commercial decisions.
Innovation and technology
- IQVIA.ai Platform: A unified agentic platform designed to connect data, technology, and analytics for optimized trial management.
- Asset Maximizer: A solution designed to help life science companies maximize the probability of success in competitive markets.
Impact on businesses
- Decision Acceleration: Reduces risks and accelerates the route to market by integrating data-driven foresight with operational efficiency.
- Performance Monitoring: Helps organizations monitor patient adherence and commercial performance against market benchmarks.
Why it may fit your brief
IQVIA is suitable for clients needing a comprehensive data-heavy partner for global commercialization. For smaller, agility-focused primary research projects, a specialized agency may offer faster turnarounds.
Global Vox Populi: best for highly targeted, verified healthcare professional recruitment
- ISO 9001
- ISO 20252
- ISO/IEC 27001
- HIPAA compliant
Strongest fitResearch directors needing precise, verified access to niche medical specialists or patient segments in the United States.
Global Vox Populi operates as a dedicated research partner, focusing on the rigorous collection of primary data from healthcare stakeholders. It maintains a significant presence in the United States, providing clients with direct access to proprietary panels rather than relying on open-market sample sourcing.
The agency is built on a foundation of high-quality, verified data, with panels profiled on up to 140 data points. It is suited for research teams that require deep access to specific specialties, including hard-to-reach diagnostic and surgical groups, while protecting strict adherence to global research standards.
Global Vox Populi panel coverage
All 12 proprietary panels together: 46,023,988 panellists across 199 markets, plus 71,411,997 patient profiles. Source: Global Vox Populi panel records, Oct 2026.
Healthcare professionals panel, in the United States
174,360 panellists
- Primary & General66,498
- Internal Medicine Subspecialties19,598
- Diagnostic & Laboratory12,588
- Acute, Peri-operative & Critical Care12,588
- Surgical Specialties11,640
- Women's & Reproductive Health11,046
Patient panel, in the United States
1,544,052 patient profiles
- Aesthetics & Cosmetic492,041
- Cardiovascular127,385
- Endocrinology & Metabolic91,143
- Ophthalmology83,979
- Dermatology75,776
- Women's Health71,571
Across 731 conditions; a patient with more than one condition is counted once per condition.
Nurses and allied health panel, in the United States
197,240 panellists
- Registered Nurses60,339
- Advanced Practice Nurses15,397
- Licensed / Practical / Enrolled Nurses14,654
- Nursing Support (Aides / HCAs)8,163
- Midwives1,860
- Pharmacists & Pharmacy Techs10,726
Scorecard: 84.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Compliance, Certifications and Security | 20 | 10/10 | ISO certificates and HIPAA policy, Oct 2026 |
| Target Audience Reach | 15 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Research Quality | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Market Presence | 10 | 2/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Analytical Capability | 5 | 8/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Client Service and Speed | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 9/10 | Based on Global Vox Populi’s documented records and supporting evidence, Oct 2026 |
| Weighted score | 100 | 84.5 |
Core services
- Healthcare Professional Research: Delivers primary research with physicians, nurses, and allied professionals using proprietary healthcare panels.
- Patient and Caregiver Insights: Conducts research using proprietary patient profiles across therapeutic areas to understand treatment journeys and unmet needs.
- Full-Service Fieldwork: Provides end-to-end data collection, from survey programming to complex qualitative research and ethnography, across 190 global markets.
Strengths
- Proprietary Panel Access: Owns and manages proprietary panels with 174,360 healthcare professionals and 1,544,052 patient profiles in the United States.
- Data Quality Assurance: Employs multi-layered validation including identity fingerprinting, geo-checks, and straight-lining detection to protect clean and reliable data delivery.
- Regulatory Compliance: Maintains ISO 9001, ISO 20252, and ISO 27001 certifications, protecting all projects follow HIPAA and international data protection standards.
Innovation and technology
- Panel Profiling Technology: Uses a proprietary platform that profiles members on 45 to 140 data points, allowing for precise targeting of low-incidence populations.
- Digital Survey Platforms: Hosts all projects on its own programmed platform, providing full control over the survey environment and respondent experience.
Impact on businesses
- Strategic Decision Support: Enables clients to make confident decisions on market entry, brand positioning, and product launch by providing verified, actionable stakeholder feedback.
- Adverse Event Management: Integrates strict BHBIA-guided protocols to monitor and report adverse events, protecting both patients and the client’s brand reputation.
Why it may fit your brief
Global Vox Populi is ideal for briefs requiring high data integrity and specific, hard-to-find audiences. For projects requiring massive secondary data integration rather than primary research, a larger, data-heavy conglomerate may be a better fit.
M3 Global Research: best for high-volume physician fieldwork and data collection
Strongest fitMarket research agencies and pharmaceutical companies requiring high-quality, reliable fieldwork from verified physicians.
M3 Global Research focuses on the fieldwork component of healthcare research, using a vast proprietary panel of verified healthcare professionals. It is a part of the global M3 group, which provides a strong foundation in physician-focused platforms.
The company prides itself on compliance and data quality, holding ISO certifications for its panels. It provides both remote and in-person data collection services to support the critical commercial and clinical decisions of pharmaceutical and research firms.
Scorecard: 84.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | m3global.com (1 page reviewed), Oct 2026 |
| Market Presence | 10 | 7/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | m3global.com (1 page reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | m3global.com (1 page reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | m3global.com (1 page reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | m3global.com (1 page reviewed), Oct 2026 |
| Weighted score | 100 | 84.0 |
Core services
- Healthcare Fieldwork: Provides solid quantitative and qualitative data collection services across more than 70 markets.
- Verified Panel Access: Offers access to a massive, ISO-certified proprietary panel of healthcare professionals and patients.
- Compliance-Focused Research: Protects high-quality data through rigorous industry training and ISO 20252 and ISO 27001 standards.
Strengths
- Panel Quality: Operates an ISO 20252 certified physician panel, providing evidence of high-quality data and stringent compliance.
- Global Scale: Maintains a massive, verified physician network that allows for rapid project execution in multiple global markets.
Innovation and technology
- Proprietary Panel Technology: Integrates industry knowledge with technology to optimize recruitment and respondent engagement.
Impact on businesses
- Reliable Data Insights: Delivers impeccable data quality that helps clients drive actionable, evidence-based improvements in patient outcomes.
- Project Efficiency: Provides fast, responsive project management that minimizes pilot interview risks and makes sure projects are delivered on time.
Why it may fit your brief
M3 is a top choice for large-scale fieldwork and panel access. For projects requiring deep strategic consulting and brand advisory, a firm like Research Partnership might be preferred.
Ipsos Healthcare: best for brand health and patient experience tracking
Strongest fitGlobal brands needing consistent, long-term tracking of market perceptions and patient experiences.
Ipsos Healthcare delivers research solutions that combine global methodology with local market understanding. It is known for its ability to track perceptions of healthcare systems and brand health across diverse markets.
The firm emphasizes actionable truths, using data from surveys, social media, and qualitative sources to help healthcare organizations make decisions. Its work focuses on understanding the experience and opinions of patients, doctors, and customers.
Scorecard: 80.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 10/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | ipsos.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 80.5 |
Core services
- Brand Health Tracking: Monitors brand performance and perceptions among key healthcare stakeholders over time.
- Patient Journey Mapping: Uncovers the experience and decision-making drivers of patients to guide commercial strategy.
- Market Strategy: Uses data to inform launch strategies and commercial performance optimization for health brands.
Strengths
- Global Methodology: Applies rigorous, science-based research standards across 32 countries to provide consistent, cross-market insights.
- Data Integration: Combines survey data with social media listening and public opinion polls for a holistic view of the healthcare environment.
Innovation and technology
- AI-Enhanced Insights: Uses proprietary AI tools to analyze data and deliver faster, more accurate insights to clients.
Impact on businesses
- Strategic Decision-Making: Helps brands act faster and more confidently by turning complex data into clear, actionable truths.
- Market Understanding: Provides deep understanding of healthcare trends, such as awareness of new therapies and public health priorities.
Why it may fit your brief
Ipsos is ideal for large-scale tracking and global strategy. For highly specific, small-scale clinical research, a firm with a more focused physician panel may be more appropriate.
Research Partnership: best for integrated life science strategy and research
Strongest fitPharma and biotech brands requiring strategic advisory and deep therapeutic benchmarking.
Research Partnership provides deep therapeutic expertise and market access research to pharma and biotech companies. It is now part of the Inizio group, which allows it to offer a broader range of advisory, transformation, and performance services.
The company focuses on the entire product lifecycle, from clinical trial development to commercial launch. Its work is characterized by the use of proprietary databases and evidence-based approaches to drive performance.
Scorecard: 79.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 9/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | researchpartnership.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 79.5 |
Core services
- Strategic Market Research: Provides custom research and proprietary syndicated data to inform decisions across the product lifecycle.
- Therapy Area Strategy: Uses deep therapeutic knowledge in areas like oncology, CNS, and immunology to support drug development.
- Performance Benchmarking: Uses the STEM database to benchmark commercial and medical performance against global best practices.
Strengths
- Therapeutic Expertise: Maintains extensive expertise across all major therapeutic areas, helping clients work through complex clinical and commercial challenges.
- Proprietary Data Assets: Uses the STEM database, the largest global source of commercial and medical performance metrics, to provide actionable benchmarking.
Innovation and technology
- Intelligent Commercialization: Connects human insight with AI and data to accelerate decision-making across the commercialization lifecycle.
Impact on businesses
- Performance Acceleration: Drives alignment and performance improvement through evidence-based approaches and clear global metrics.
- Strategic Transformation: Supports clients in shaping the future of health by uniting strategy, insights, and innovation.
Why it may fit your brief
Research Partnership is ideal for long-term strategic support and performance benchmarking. For transactional, quick-turnaround fieldwork, a dedicated fieldwork agency might be more cost-effective.
Sago: best for agile qualitative and quantitative data collection
Strongest fitTeams needing rapid, flexible access to diverse healthcare audiences for agile testing and concept development.
Sago, formerly Schlesinger Group, provides a wide array of research services with a focus on agility and flexibility. It serves the healthcare sector by connecting clients with physicians, patients, and other stakeholders.
The company maintains a strong network of research facilities and digital tools, enabling both in-person and online methodologies. It emphasizes speed and the ability to combine quantitative and qualitative approaches to meet specific project needs.
Scorecard: 78.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | sago.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 8/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | sago.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 7/10 | sago.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 8/10 | sago.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 78.5 |
Core services
- Healthcare Research Solutions: Provides specialized support for brand penetration studies, concept testing, and segmentation in the healthcare space.
- Digital Qualitative Solutions: Offers online tools for focus groups, community engagement, and in-depth interviews with healthcare stakeholders.
- DIY Quantitative Platform: Provides Methodify, a self-serve platform for rapid, agile quantitative research without long-term subscriptions.
Strengths
- Global Reach: Accesses a vast network of respondents and research facilities to support both local and international project requirements.
- Agile Methodology: Offers flexible, iterative research options that allow clients to move quickly from concept to execution.
Innovation and technology
- SagoVerify: A data quality initiative designed to standardize and raise the benchmark for research data integrity.
Impact on businesses
- Operational Efficiency: Reduces research timelines and costs through the use of automated tools and agile project management.
- Informed Decision-Making: Enables evidence-based decisions in marketing and product development through reliable stakeholder feedback.
Why it may fit your brief
Sago is excellent for agile, multi-method research projects. For highly regulated, long-term clinical strategy, specialized advisory firms may provide more tailored guidance.
Sermo: best for physician-to-physician sentiment and clinical discussion
Strongest fitBrands needing rapid, authentic sentiment data from a large pool of verified physicians.
Sermo operates a large online medical community where physicians and other healthcare professionals connect to discuss clinical cases, news, and career challenges. It uses this community to provide research partners with access to physician sentiment and real-world perspectives.
The platform is designed to support authentic engagement, making it a unique resource for understanding how doctors think about treatments and clinical trends in their daily practice.
Scorecard: 78.0 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 9/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 9/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 4/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 7/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | sermo.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 78.0 |
Core services
- HCP Sentiment Research: Provides research and engagement solutions to understand changing healthcare dynamics through direct physician feedback.
- Clinical Insights: Offers access to physician drug ratings, reviews, and clinical perspectives on challenging treatment cases.
- Career and Compensation Research: Engages HCPs on professional topics, including career development, compensation, and workplace challenges.
Strengths
- Massive HCP Community: Connects clients to over 1.5 million verified physicians and healthcare professionals across the globe.
- Authentic Engagement: Provides a space for real-world, peer-to-peer discussions that reveal the true clinical drivers behind treatment choices.
Innovation and technology
- HCP Sentiment Series: A research series developed in partnership with the industry to track changing healthcare dynamics.
Impact on businesses
- Strategic Business Insights: Transforms physician feedback into actionable business insights that support brand lifecycle management.
- Clinical Understanding: Helps brands understand the physician perspective on clinical challenges, AI integration, and patient expectations.
Why it may fit your brief
Sermo is best for understanding physician sentiment and clinical practice. For formal, structured brand tracking or patient-journey deep dives, other agencies may offer more comprehensive analytical models.
Kantar: best for large-scale consumer health and brand equity tracking
Strongest fitConsumer health and large pharmaceutical brands needing broad market and media performance insights.
Kantar is a large-scale data and analytics provider that uses human understanding to guide brand growth. It has a dedicated healthcare practice that helps brands work through complex media and market environments.
The company uses extensive consumer data points and proprietary brand equity studies to provide insights that are both broad and deep. It is known for its ability to integrate survey data with third-party sources for a holistic view of the audience.
Scorecard: 76.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 9/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 6/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 8/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | kantar.com (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 76.5 |
Core services
- Brand Strategy: Uses the Blueprint for Brand Growth to help businesses build sustainable, profitable health brands.
- Creative and Media Effectiveness: Tests advertising campaigns to protect they capture attention and drive return on investment.
- Survey Solutions: Provides agile survey platforms and omnibus services for rapid data collection across global markets.
Strengths
- Data Depth: Accesses 6.5 billion consumer data points to inform brand strategy and audience validation.
- Anti-Fraud Technology: Uses Qubed AI, a proprietary system that uses deep neural networks to stop panel fraud in real-time.
Innovation and technology
- Qubed AI: A next-generation technology designed to identify fraudulent activity and improve respondent quality.
Impact on businesses
- Brand Growth: Enables brands to make informed decisions that lead to sustainable growth and higher campaign profits.
- Holistic Insights: Breaks down data silos by connecting survey results with third-party and first-party data sources.
Why it may fit your brief
Kantar is excellent for consumer-facing health brand strategy. For highly clinical or niche therapy area research, a more specialized healthcare agency may offer deeper expertise.
Escalent: best for behavioral science-driven healthcare strategy
Strongest fitBrands seeking to influence patient or provider behavior through deep psychological and behavioral insights.
Escalent integrates behavioral science with data analytics to provide strategic advice to healthcare and pharma clients. The firm focuses on translating human behavior into ideas that change brand challenges into opportunities.
Its approach combines primary research with advanced data science, emphasizing the use of AI to enhance human expertise. It works with clients to build data-driven relationships with their healthcare audiences.
Scorecard: 74.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 7/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 7/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Market Presence | 10 | 8/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | escalent.co (4 pages reviewed), Oct 2026 |
| Weighted score | 100 | 74.5 |
Core services
- Behavioral Science Consulting: Applies principles of behavioral science to drive customer engagement and sustained behavior change.
- Market Exploration: Assesses market dynamics and competitive positioning to guide brand strategy and product development.
- Customer Experience (CX): Maps the customer journey and optimizes touchpoints to build stronger, more responsive brand relationships.
Strengths
- Human-Guided AI: Uses AI ethically to enhance industry knowledge while maintaining human-in-the-loop review for data quality.
- Behavioral Expertise: Deeply incorporates psychological and behavioral science principles into research design and strategic recommendations.
Innovation and technology
- Choice Architecture: Uses behavioral research to adjust choice environments and improve decision-making for patients and HCPs.
Impact on businesses
- Strategic Clarity: Helps brands see clearly, mitigate risks, and act decisively in competitive and regulated environments.
- Actionable Segmentation: Builds durable segmentation models that drive long-term return on investment for marketing and product teams.
Why it may fit your brief
Escalent excels in behavioral strategy and complex segmentation. For simple, high-volume fieldwork requests, a more traditional data collection agency might be more efficient.
Adelphi Research: best for behavioral and psychological research in pharma
Strongest fitPharma brands needing to understand the underlying, often subconscious, drivers of physician and patient behavior.
Adelphi Research focuses on healthcare market research that inspires action. It uses a multi-perspective approach to help clients understand the emotional drivers behind treatment selection and patient outcomes.
The company emphasizes innovation, constantly exploring new methods like gamification and neuro-psychology to uncover unarticulated drivers of decision-making. Its consultants work across multiple therapy areas to provide strategic solutions to brand challenges.
Scorecard: 74.5 out of 100
| Criterion | Weight | Score | Evidence and date |
|---|---|---|---|
| Industry Expertise | 20 | 8/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Compliance, Certifications and Security | 20 | 8/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Target Audience Reach | 15 | 7/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Research Quality | 10 | 8/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Market Presence | 10 | 3/10 | Google results for this search and company size, Oct 2026 |
| Methodological Breadth | 10 | 9/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Analytical Capability | 5 | 9/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Client Service and Speed | 5 | 8/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Pricing and Feasibility Transparency | 5 | 7/10 | adelphiresearch.com (6 pages reviewed), Oct 2026 |
| Weighted score | 100 | 74.5 |
Core services
- Strategic Market Research: Provides insights that impact strategic decision-making for pharmaceutical and healthcare organizations.
- Behavioral Consulting: Applies psychological and social science to uncover drivers of treatment selection and patient types.
- Agile Research Methods: Uses agile platforms and new technologies to provide rapid results for burning research questions.
Strengths
- Innovative Methodologies: Actively uses gamification and neuro-psychology to overcome traditional research biases and understand subconscious behavior.
- Inclusive Culture: Fosters a diverse and inclusive workplace, including the active integration of individuals with autism, which drives unique perspectives and innovation.
Innovation and technology
- Illuminate Innovation Lab: An internal lab where the team develops and tests new research techniques to enhance client insights.
Impact on businesses
- Pharmaceutical Change: Drives significant changes in healthcare regulation and patient engagement through deep-rooted research insights.
- Brand Strategy Success: Helps teams transform complexity into clarity and momentum, driving meaningful success for their brands.
Why it may fit your brief
Adelphi is highly specialized in behavioral and emotional insight. For large-scale data collection or routine tracking, a larger agency may offer greater economies of scale.
How HCP and patient verification actually works in the United States
Make sure every healthcare respondent is verified through license checks and continuous re-validation.
Professional License Verification
For healthcare professionals, firms must verify current status against official medical registries or licensing boards in the United States. This prevents unqualified individuals from influencing clinical data. Ask for evidence of their verification process and how frequently they re-validate members, as license status can change or lapse over time.
Identity and Fraud Detection
Reliable firms employ digital identity fingerprinting and geo-location checks to detect bots, VPNs, and fraudulent sign-ups. Ask how they identify non-genuine participants, particularly in high-incentive studies. A common pitfall is relying on self-reporting; always protect the firm uses objective, automated tools to validate the respondent’s identity before they join the panel.
Straight-lining and Speeding Checks
During surveys, firms must use algorithmic checks to detect straight-lining (selecting the same answer for every question) and speeding (completing the survey in an unrealistic timeframe). These behaviors indicate poor quality data. Ask for a summary of their data-cleansing process and how many respondents are typically removed per project due to these quality flags.
Double Opt-in and Consent
Data quality starts with consent. Protect the provider uses a double opt-in process and maintains granular, revocable consent from all participants. This is essential for compliance with HIPAA and data protection laws in the United States. Without this, you risk legal exposure and poor-quality data from unengaged or improperly recruited members.
How to choose the right provider in the United States
Prioritize providers that combine clinical expertise with transparent data quality controls.
- Assess panel ownership: Determine if the firm owns its panels or rents them from third parties, as ownership usually correlates with higher data quality and better respondent engagement.
- Review compliance standards: Request proof of ISO certifications and documented procedures for HIPAA compliance, which are essential for protecting patient and healthcare data in the United States.
- Evaluate analytical depth: Make sure the firm can move beyond basic data collection to provide strategic insights that directly address your brand’s specific challenges.
- Verify panel profiling: Check how deeply the panels are profiled so you can target hard-to-reach specialists or specific patient populations effectively.
- Test responsiveness: Engage the team early to assess their transparency regarding project feasibility and their ability to troubleshoot fieldwork issues.
Questions to ask before you commission
- What specific verification processes do you use to make sure your healthcare professionals are currently licensed in the United States?
- How often do you re-validate your panel members, and what happens when a member’s status changes?
- Can you provide your most recent audit report or certification details for ISO 20252 and HIPAA compliance?
- What percentage of your data is typically removed during your quality control process for straight-lining or speeding?
- How do you handle adverse event reporting in your patient-focused studies to protect regulatory compliance?
- Can you describe your experience with my specific therapeutic area and the size of the relevant panel in the United States?
Common pitfalls to avoid
- Over-reliance on open sample: Relying on rented, open-market sample often leads to poor-quality data and high rates of fraudulent participants in healthcare studies.
- Ignoring compliance documentation: Failing to verify a partner's HIPAA compliance and adverse event reporting procedures can expose your brand to significant legal and ethical risk.
- Underestimating feasibility: Accepting unrealistic feasibility promises for niche specialist groups often leads to delayed timelines and compromised project outcomes.
- Prioritizing speed over quality: Choosing the fastest, cheapest provider without checking their data-cleansing protocols often results in data that cannot be used for critical decisions.
What a feasibility check should include
Demand an honest, evidence-based feasibility assessment before signing any project contract.
Audience accessibility check
A proper assessment should confirm the exact number of active, verified professionals within the required specialty in the United States.
Incidence rate validation
The partner must estimate the true incidence rate for the target population to avoid mid-project budget increases or recruitment failure.
Timeline realism
Protect the feasibility plan accounts for the time required for high-quality recruitment and data validation, rather than just the survey completion time.
Capacity planning
The provider should be transparent about current panel load and their ability to dedicate the necessary resources to your project.
Conclusion
Choosing the right partner from the list of healthcare market research companies in the United States requires a clear understanding of your project requirements. For deep, verified access to medical specialists and patients, independent agencies with proprietary panels are essential. If your needs involve massive data integration and commercial modeling, larger data-focused conglomerates are better suited. Always prioritize firms that can demonstrate their commitment to data quality, compliance, and transparent feasibility reporting.
Use the scorecard provided to weigh each provider against your specific priorities. A successful partnership is built on reliable data and clear, strategic communication. By demanding evidence of verification and compliance early in the process, you protect your brand and make sure that the insights you receive are both actionable and trustworthy.
Planning research in the United States? Tell us your audience, markets and timeline, and we will come back with a feasibility check and recommended approach.
Frequently asked questions
What are the top healthcare market research companies in the United States?
The top companies vary based on your specific needs. For primary research and verified panels, Global Vox Populi and M3 Global Research are recognized for their healthcare focus. For large-scale data and commercial strategy, firms like IQVIA and Research Partnership are leaders. For brand tracking and behavioral insights, Ipsos Healthcare, Escalent, and Adelphi Research provide specialized capabilities.
How do I choose a healthcare market research partner?
Start by evaluating their panel ownership, industry-specific compliance certifications like HIPAA, and their ability to reach your precise target audience. Look for a partner that offers transparent feasibility reporting and can provide evidence of their data-cleansing and respondent verification processes before you sign any contract.
What services do healthcare market research firms provide?
These firms provide a range of services including primary data collection through surveys and interviews, patient journey mapping, brand health tracking, market access research, and predictive commercial analytics. They also offer strategic consulting to turn this data into actionable insights for product development, launch, and ongoing brand management.
Which market research companies specialize in pharmaceutical research?
Many of the leading firms have dedicated pharmaceutical practices. Research Partnership, IQVIA, and Adelphi Research are particularly well-regarded for their deep expertise in pharma-specific challenges, including clinical trial support, market access, and brand strategy within the highly regulated healthcare environment of the United States.
How does healthcare market research help life science brands?
It provides the evidence required for critical decisions throughout the product lifecycle. Research helps brands understand unmet patient needs, the drivers of physician treatment selection, the effectiveness of marketing communications, and the competitive environment, ultimately leading to more successful product launches and improved patient outcomes.
Are there HIPAA-compliant market research firms in the United States?
Yes, reputable healthcare market research firms in the United States must be HIPAA compliant. This makes sure that any patient health data collected during research is protected according to federal law. You should always verify that your chosen partner has documented HIPAA procedures and a clear process for handling sensitive data.
What is the importance of proprietary panels in healthcare research?
Proprietary panels consist of members recruited and verified directly by the agency. This protects higher data quality, better respondent engagement, and more consistent profiling compared to rented sample. It allows researchers to target specific, hard-to-reach medical specialists with greater precision and reliability.
How do I protect the quality of healthcare research data?
Demand transparency regarding the provider's data-cleansing process. This should include identity fingerprinting, geo-location checks, and algorithms to detect speeding, straight-lining, and bot activity. A high-quality partner will provide evidence of these controls and be open about the percentage of respondents removed during their validation process.